BlackRock Investment Management’s Argos Therapeutics, Inc. ARGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $328K | Buy |
3,343
+19
| +0.6% | +$1.86K | ﹤0.01% | 3129 |
|
|
2016
Q3 | $330K | Buy |
3,324
+1,346
| +68% | +$134K | ﹤0.01% | 3143 |
|
|
2016
Q2 | $243K | Buy |
1,978
+1,891
| +2,174% | +$232K | ﹤0.01% | 3243 |
|
|
2016
Q1 | $11K | Hold |
87
| – | – | ﹤0.01% | 3572 |
|
|
2015
Q4 | $4K | Buy |
87
+8
| +10% | +$368 | ﹤0.01% | 3923 |
|
|
2015
Q3 | $8K | Hold |
79
| – | – | ﹤0.01% | 3797 |
|
|
2015
Q2 | $11K | Buy |
79
+41
| +108% | +$5.71K | ﹤0.01% | 3688 |
|
|
2015
Q1 | $7K | Hold |
38
| – | – | ﹤0.01% | 3784 |
|
|
2014
Q4 | $8K | Hold |
38
| – | – | ﹤0.01% | 3773 |
|
|
2014
Q3 | $8K | Hold |
38
| – | – | ﹤0.01% | 3768 |
|
|
2014
Q2 | $6K | Sell |
38
-434
| -92% | -$68.5K | ﹤0.01% | 3840 |
|
|
2014
Q1 | $94K | Buy |
+472
| New | +$94K | ﹤0.01% | 3282 |
|